[VNDA]
Mid
Mid
2026-09-30 20:07:58
Vanda posts late-stage trial win for HETLIOZ in DSWPD, setting up another label expansion
Row
2026-08-10 20:55:53
H.C. Wainwright cuts Vanda Pharmaceuticals price target to $20
Mid
2026-07-17 05:39:10
Vanda gets EMA orphan drug designation for imsidolimab in GPP